Human Vaccines & Immunotherapeutics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2025-02-19 匿名用户

编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2024-02-28 ms5000001373452742 来自福建省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语

116 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2023-02-07 1484b4c3m87暂无昵称来自江苏省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：免疫治疗
经验分享：11月10号提交，2月7号接受，审稿人没有太为难

133 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2024-11-30 ms3000000634641881

这个期刊现在是只有OA了吗,这也太贵了。

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2020-11-21 luancdc

审稿速度:6.0 | 投稿命中率:50.0
经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，

225 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2022-11-26 ms3000001074290381 来自上海

请问提交文稿后怎么撤回呢？

136 0

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2022-01-20 口口口

两个月没有消息是要被拒了吗？

147 0

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2021-12-27 衣谷

一般期刊要求几张图/几个表？

138 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2021-12-27 rayms

如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？

138 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2252609, encodeId=829122526091b, content=编辑注意：该期刊将要求包含传记说明。请为每位作者提供简短的传记说明。这可以根据您的部门网站或学术网络简介改编，并且应该相对简短（例如不超过 200 字）。所有通讯作者都必须包含简短的传记说明，例如，包括您在您所在机构的角色和您的学科专业，例如 Brown 教授是布里斯托大学的微生物学教授，专门研究免疫工程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Feb 19 10:06:50 CST 2025, time=2025-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240128, encodeId=79da22401280c, content=这个期刊现在是只有OA了吗,这也太贵了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1d39311616, createdName=ms3000000634641881, createdTime=Sat Nov 30 23:13:00 CST 2024, time=2024-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]

2015-07-29 xn8008

审稿速度:2.0 | 投稿命中率:25.0
经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！

577 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务